Kathleen E. Simpson, MD, Elizabeth Pruitt, MSPH, James K

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Photodynamic Laser Therapy for Lesions in the Airway

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

What Predicts Long-Term Survival After Heart Transplantation

Elizabeth A. David, MD, David T

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Effect of Gastrointestinal Malformations on the Outcomes of Patients With Congenital Heart Disease Carlos M. Mery, MD, MPH, Luis E. De León, MD, J. Rubén.

Outcomes of Reintervention on the Autograft After Ross Procedure

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Andreas Zierer, MD, Spencer J. Melby, MD, Rochus K

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Heart Transplantation for the Failing Fontan

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

James R. Edgerton, MD, Morley A

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

Long-Term Survival After Arterial Versus Atrial Switch in d-Transposition of the Great Arteries Alexander Kiener, MD, MPH, Michael Kelleman, MSPH, Courtney.

Castigliano M. Bhamidipati, DO, MS, George J

Less Is More in Post Pediatric Heart Transplant Care

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Operative Results and Outcomes in Children With Shone's Anomaly

Denton A. Cooley, August 22, 1920, to November 18, 2016

The Survival Benefit of Simultaneous Heart-Kidney Transplantation Extends Beyond Dialysis-Dependent Patients Arman Kilic, MD, Joshua C. Grimm, MD, Glenn.

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Surgery in Adults With Congenital Heart Disease: Risk Factors for Morbidity and Mortality Brian Kogon, MD, Joanna Grudziak, MA, Anurag Sahu, MD, Maan.

Jennifer K. Peterson, MS, Lazaros K. Kochilas, MD, MSCR, Kirsti G

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Effect of Intercurrent Operation and Cerebral Oxygenation on Developmental Trajectory in Congenital Heart Disease George M. Hoffman, MD, Cheryl L. Brosig,

Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation Steven A. Farmer, MD, PhD, Kathleen L. Grady,

Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant Stefan Klotz, MD, Frauke Wenzelburger, MD, Joerg.

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Rejection with heart failure after pediatric cardiac transplantation

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Lung Function and ECMO After Lung Transplantation

Trends in the Indications and Survival in Pediatric Heart Transplants: A 24-year Single- Center Experience in 307 Patients Rochus K. Voeller, MD, Deirdre.

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Raheel Rizwan, MD, Farhan Zafar, MD, Roosevelt Bryant, MD, James S

Characteristics of Malignant Pleural Mesothelioma in Women

Fontan Failure and Death in Contemporary Fontan Circulation: Analysis From the Last Two Decades Yasuhiro Kotani, MD, PhD, Devin Chetan, MD, Jiaquan Zhu,

A. Thomas Pezzella, MD, Sari D

Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent? Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Dana Y. Fuhrman, DO, MS, Lan G

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Non-Fontan Adult Congenital Heart Disease Transplantation Survival Is Equivalent to Acquired Heart Disease Transplantation Survival Josef Besik, MD,

Multivariate Predictors of Heart Transplantation Outcomes in the Era of Chronic Mechanical Circulatory Support Stavros G. Drakos, MD, PhD, Abdallah G.

Raluca Ionescu-Ittu, MS, Andrew S

Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures Simon Maltais, MD, PhD,

Use of Ventricular Assist Devices in Children Across the United States: Analysis of 7.5 Million Pediatric Hospitalizations David L.S. Morales, MD, Farhan.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Late Consequences of a Much Earlier Decision

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Heart Transplant Program Volume Is Not a Measure of Quality

Early and Late Outcomes of Aortic Valve Replacement in Dialysis Patients Keisuke Tanaka, MD, Kazuyoshi Tajima, MD, Yoshiyuki Takami, MD, Noritaka Okada,

Presentation transcript:

Fontan Patient Survival After Pediatric Heart Transplantation Has Improved in the Current Era Kathleen E. Simpson, MD, Elizabeth Pruitt, MSPH, James K. Kirklin, MD, David C. Naftel, PhD, Rakesh K. Singh, MD, MS, R. Erik Edens, MD, PhD, Aliessa P. Barnes, MD, Charles E. Canter, MD The Annals of Thoracic Surgery Volume 103, Issue 4, Pages 1315-1320 (April 2017) DOI: 10.1016/j.athoracsur.2016.08.110 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Hazard analysis shows survival in Fontan patients after transplant (A) in the early era (1993 to 2006) and (B) late era (2007 to 2014). The range bars show the SD, and the dashed lines show the 70% confidence interval. (PHTS = Pediatric Heart Transplant Study.) The Annals of Thoracic Surgery 2017 103, 1315-1320DOI: (10.1016/j.athoracsur.2016.08.110) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Hazard analysis of survival after transplant for non-Fontan patients in the (A) in the early era (1993 to 2006) and (B) late era (2007 to 2014). The range bars show the SD, and the dashed lines show the 70% confidence interval. (PHTS = Pediatric Heart Transplant Study.) The Annals of Thoracic Surgery 2017 103, 1315-1320DOI: (10.1016/j.athoracsur.2016.08.110) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier analysis of survival comparison between groups and across eras. Fontan patient postheart transplant survival significantly improved from the early to late era. (CHD = congenital heart disease; PHTS = Pediatric Heart Transplant Study.) The Annals of Thoracic Surgery 2017 103, 1315-1320DOI: (10.1016/j.athoracsur.2016.08.110) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions